Laurel Wealth Advisors (California)’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$484K Buy
2,019
+67
+3% +$15K 0.05% 363
2022
Q3
$358K Hold
1,952
0.04% 427
2022
Q2
$328K Buy
1,952
+815
+72% +$175K 0.03% 467
2022
Q1
$285K Buy
1,137
+27
+2% +$6.78K 0.02% 603
2021
Q4
$285K Buy
+1,110
New +$272K 0.02% 636

Other funds holding HCA

Laurel Wealth Advisors (California)'s HCA Position: Q4 2022 in Review

Laurel Wealth Advisors (California) increased its HCA Healthcare (HCA) stake by 3.4% in Q4 2022, buying an estimated $15K and bringing the position to 2,019 shares worth $484K. The position accounts for 0.05% of the portfolio, ranked #363.

Laurel Wealth Advisors (California) first reported a position in HCA in Q4 2021 and has held it in 5 quarters since. 961 funds tracked by Wall St. Rank hold HCA as of Q4 2022.

  • Laurel Wealth Advisors (California) held 2,019 shares of HCA Healthcare worth $484K as of Q4 2022.
  • Laurel Wealth Advisors (California) bought 67 HCA Healthcare shares in Q4 2022, an estimated $15K.
  • HCA Healthcare made up 0.05% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #363 holding.
  • Laurel Wealth Advisors (California) first reported a position in HCA Healthcare in Q4 2021 and has held it in 5 quarters since.
  • 961 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.